A nationwide Swedish cohort study published in Neurology found that pregnancy was not associated with increased risk of serious #myastheniagravis exacerbations requiring hospitalization or new symptoms.
practicalneurology.com/news/…
🧪 Clinical Trial in Focus: The phase 3️⃣ RELIEVE trial is evaluating the oral BTK inhibitor remibrutinib as an add-on therapy for #gMG
The study includes AChR , MuSK , and double-seronegative patients, with MG-ADL change at 6 months as the primary end point
Read the full article here: hubs.li/Q04ncMmr0#MyastheniaGravis#Neurology#BrainHealth